M. Chris Runken

778 total citations
46 papers, 544 citations indexed

About

M. Chris Runken is a scholar working on Psychiatry and Mental health, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, M. Chris Runken has authored 46 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Psychiatry and Mental health, 9 papers in Pathology and Forensic Medicine and 9 papers in Epidemiology. Recurrent topics in M. Chris Runken's work include Migraine and Headache Studies (16 papers), Trigeminal Neuralgia and Treatments (9 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). M. Chris Runken is often cited by papers focused on Migraine and Headache Studies (16 papers), Trigeminal Neuralgia and Treatments (9 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). M. Chris Runken collaborates with scholars based in United States, Spain and United Kingdom. M. Chris Runken's co-authors include Stephen H. Landy, Wayne N. Burton, K Downs, Richard B. Lipton, Deborah Gelinas, Dawn C. Buse, Frederick J. Derosier, Christopher F. Bell, Michael L. Reed and Robert A. Nicholson and has published in prestigious journals such as Blood, The Journal of Immunology and PEDIATRICS.

In The Last Decade

M. Chris Runken

40 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Chris Runken United States 13 320 187 132 77 75 46 544
Önder Cangüven Qatar 17 381 1.2× 76 0.4× 101 0.8× 160 2.1× 8 0.1× 56 785
Ramón Blanco United States 10 265 0.8× 51 0.3× 77 0.6× 44 0.6× 10 0.1× 13 458
Paul G. Mathew United States 15 296 0.9× 191 1.0× 111 0.8× 76 1.0× 70 0.9× 46 572
Colleen Harris Canada 11 91 0.3× 421 2.3× 46 0.3× 12 0.2× 186 2.5× 19 570
Kristina Källén Sweden 14 373 1.2× 22 0.1× 30 0.2× 31 0.4× 43 0.6× 30 641
Judy Lee United States 13 185 0.6× 42 0.2× 107 0.8× 353 4.6× 47 0.6× 35 839
Lin Qiao China 13 154 0.5× 91 0.5× 42 0.3× 46 0.6× 103 1.4× 35 391
Marine Auffret France 13 37 0.1× 203 1.1× 15 0.1× 28 0.4× 103 1.4× 47 531
Brian C. Cooper United States 12 75 0.2× 90 0.5× 66 0.5× 109 1.4× 4 0.1× 21 782

Countries citing papers authored by M. Chris Runken

Since Specialization
Citations

This map shows the geographic impact of M. Chris Runken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Chris Runken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Chris Runken more than expected).

Fields of papers citing papers by M. Chris Runken

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Chris Runken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Chris Runken. The network helps show where M. Chris Runken may publish in the future.

Co-authorship network of co-authors of M. Chris Runken

This figure shows the co-authorship network connecting the top 25 collaborators of M. Chris Runken. A scholar is included among the top collaborators of M. Chris Runken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Chris Runken. M. Chris Runken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Candel, Francisco Javier, Elisabet Viayna, Daniel Callejo, et al.. (2021). Social Restrictions versus Testing Campaigns in the COVID-19 Crisis: A Predictive Model Based on the Spanish Case. Viruses. 13(5). 917–917. 3 indexed citations
2.
Gehrie, Eric A., Elisabet Viayna, Christopher Blanchette, et al.. (2021). Longer Hospitalizations, Increased Inpatient Mortality and Costs Are Associated with Alloimmunization Among Patients with Myelodysplastic Syndromes. Blood. 138(Supplement 1). 1075–1075.
3.
Sandhaus, Robert A., et al.. (2020). <p>Comorbidity Associations with AATD Among Commercially Insured and Medicare Beneficiaries with COPD in the US</p>. International Journal of COPD. Volume 15. 2389–2397. 2 indexed citations
4.
Allen, Jeffrey A., Deborah Gelinas, Miriam Freimer, M. Chris Runken, & Gil I. Wolfe. (2019). Immunoglobulin administration for the treatment of CIDP: IVIG or SCIG?. Journal of the Neurological Sciences. 408. 116497–116497. 32 indexed citations
5.
6.
Runken, M. Chris, et al.. (2017). Evaluation of Physician-Patient Interactions Regarding Route of Administration for Immunoglobulin Therapy in Primary Immunodeficiency Disease. Journal of Allergy and Clinical Immunology. 139(2). AB217–AB217.
7.
Runken, M. Chris, et al.. (2017). Patient and Physician-interpreted Patient Preferences for Administration of Immunoglobulin Therapy in Primary Immunodeficiency Disorder. Journal of Allergy and Clinical Immunology. 139(2). AB145–AB145. 1 indexed citations
8.
Runken, M. Chris & Juan Marcos González. (2016). Using patients’ stated preferences for immunoglobulin therapies to evaluate administration features in current treatments. The Journal of Immunology. 196(1_Supplement). 130.5–130.5. 1 indexed citations
9.
Bril, Vera, Christopher M. Blanchette, Joshua Noone, et al.. (2016). The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy. Journal of Diabetes and its Complications. 30(7). 1401–1407. 39 indexed citations
10.
Blanchette, Christopher M., et al.. (2015). Natural Progression of Alpha-1 Antitrypsin Deficiency Among Hospitalized COPD Patients in the US. CHEST Journal. 148(4). 497A–497A. 1 indexed citations
11.
12.
13.
Gaetano, Giovanni de, Hongbo Yang, M. Chris Runken, et al.. (2013). Impact of mirabegron treatment and symptom severity on work productivity and activity impairment in patients with overactive bladder. Value in Health. 16(3). A183–A184. 1 indexed citations
14.
Derosier, Frederick J., Donald W. Lewis, Andrew D. Hershey, et al.. (2012). Randomized Trial of Sumatriptan and Naproxen Sodium Combination in Adolescent Migraine. PEDIATRICS. 129(6). e1411–e1420. 36 indexed citations
15.
Coon, Cheryl D., et al.. (2012). The Development of a Survey to Measure Completeness of Response to Migraine Therapy. Headache The Journal of Head and Face Pain. 52(4). 550–572. 6 indexed citations
16.
Cady, Roger, Merle L. Diamond, Michael P. Diamond, et al.. (2011). Sumatriptan–Naproxen Sodium for Menstrual Migraine and Dysmenorrhea: Satisfaction, Productivity, and Functional Disability Outcomes. Headache The Journal of Head and Face Pain. 51(5). 664–673. 24 indexed citations
17.
Stewart, Walter F., et al.. (2011). Longitudinal Change in Migraine Headache-Days and Indirect Cost Consequences. Journal of Occupational and Environmental Medicine. 53(5). 478–487. 11 indexed citations
18.
Landy, Stephen H., et al.. (2010). Assessing the Impact of Migraine Onset on Work Productivity. Journal of Occupational and Environmental Medicine. 53(1). 74–81. 34 indexed citations
19.
Burton, Wayne N., Stephen H. Landy, K Downs, & M. Chris Runken. (2009). The Impact of Migraine and the Effect of Migraine Treatment on Workplace Productivity in the United States and Suggestions for Future Research. Mayo Clinic Proceedings. 84(5). 436–445. 81 indexed citations
20.
Black, Libby, M. Chris Runken, Michael Eaddy, & Manan Shah. (2007). Chronic disease prevalence and burden in elderly men: an analysis of Medicare medical claims data.. PubMed. 33(4). 68–78. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Önder Cangüven Breakdown of academic impact, for papers by Ramón Blanco Breakdown of academic impact, for papers by Paul G. Mathew Breakdown of academic impact, for papers by Colleen Harris Breakdown of academic impact, for papers by Kristina Källén Breakdown of academic impact, for papers by Judy Lee Breakdown of academic impact, for papers by Lin Qiao Breakdown of academic impact, for papers by Marine Auffret Breakdown of academic impact, for papers by Brian C. Cooper
Rankless by CCL
2026